Related Experiment Video

Updated: Aug 19, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes

H James Hnatyszyn1

  • 1Bayer Institute for Clinical Investigation (BICI), Bayer HealthCare - Diagnostics Division, Berkeley, CA, USA. James.hnatyszyn.b@bayer.com

Antiviral Therapy
|March 9, 2005
PubMed

Insights

Hepatitis C virus (HCV) infection causes chronic liver disease globally. Determining HCV genotypes is crucial for guiding effective treatment and managing patient care.

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Chronic hepatitis C virus (HCV) infection is a significant global health issue, affecting over 175 million people worldwide.
  • HCV infection can lead to severe liver conditions such as cirrhosis and hepatocellular carcinoma (HCC), necessitating complex treatments and long-term management.
  • Identifying factors influencing disease progression and treatment response is vital for optimizing patient care and healthcare resource allocation.

Purpose of the Study:

  • To review the significance of determining hepatitis C virus (HCV) genotypes in clinical practice.
  • To provide background information on HCV genotype determination and its relevance in managing chronic HCV infections.
  • To highlight the role of viral genome characterization in patient management and therapeutic strategies.

Main Methods:

  • This review synthesizes existing literature on hepatitis C virus (HCV) genotype determination.
  • It examines epidemiological, pathological, and viral characteristics relevant to disease progression and treatment response.
  • The focus is on the clinical utility of HCV genome characterization.

Main Results:

  • Hepatitis C virus (HCV) genotype determination is a key parameter in guiding the clinical management of chronic HCV infections.
  • Understanding viral characteristics aids in predicting disease progression, severity, and response to therapy.
  • Characterization of the viral genome provides essential insights for effective therapeutic regimens and long-term patient management.

Conclusions:

  • Determination of hepatitis C virus (HCV) genotype is essential for personalized treatment strategies.
  • Viral genome characterization offers valuable information for clinicians in managing chronic HCV infections.
  • Effective management of HCV requires a comprehensive understanding of viral factors influencing disease outcomes.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...